ADAD1P2

Across TCGA pan-cancer cohorts, ADAD1P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ADAD1P2’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ADAD1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types ADAD1P2 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and STAD are the cancer types where ADAD1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ADAD1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.046	<.001	4	view →
STAD	Male	II,III,IV	+0.032	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ADAD1P2–THCA

Open the THCA breakdown →